Literature DB >> 8541030

Hospital discharge register data in the assessment of trends in acute myocardial infarction. FINMONICA AMI Register Study Team.

M Mähönen1, H Miettinen, K Pyörälä, A Molarius, V Salomaa, K Kuulasmaa.   

Abstract

We evaluated the reliability hospital discharge register data in the assessment of acute myocardial infarction trends. In the FINMONICA study areas, trends in age standarized attack rates for the years 1983-90 were calculated independently from two sources: the nationwide Finnish hospital discharge register and the FINMONICA acute myocardial infarction register. The trends were compared by a statistical regression model. The trends obtained from the hospital discharge register were very similar to the trends obtained from the FINMONICA acute myocardial infarction register. The attack rates differed significantly, however, and the change in the International Classification of Diseases version from version 8 to version 9 brought on a change in the attack rates obtained from the hospital discharge register. Thus, hospital discharge register data can be used to assess acute myocardial infarction trends in the community. However, modifications of the International Classification of Diseases codes (new versions of the classification) and changes in the clinical use of the codes for coronary heart disease can have an impact on the attack rates obtained from the hospital discharge register, and the reliability of the hospital discharge register data should be regularly assessed.

Entities:  

Mesh:

Year:  1995        PMID: 8541030     DOI: 10.3109/07853899509002467

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  8 in total

1.  The effect of birth order and parental age on the risk of type 1 and 2 diabetes among young adults.

Authors:  N Lammi; E Moltchanova; P Blomstedt; J G Eriksson; O Taskinen; C Sarti; J Tuomilehto; M Karvonen
Journal:  Diabetologia       Date:  2007-10-18       Impact factor: 10.122

2.  A high incidence of type 1 diabetes and an alarming increase in the incidence of type 2 diabetes among young adults in Finland between 1992 and 1996.

Authors:  N Lammi; O Taskinen; E Moltchanova; I-L Notkola; J G Eriksson; J Tuomilehto; M Karvonen
Journal:  Diabetologia       Date:  2007-05-11       Impact factor: 10.122

3.  Feasibility of determining myocardial infarction type from medical record review.

Authors:  Ken S Woo; William A Ghali; Danielle A Southern; Jack V Tu; Gerry Parsons; Michelle M Graham
Journal:  Can J Cardiol       Date:  2008-02       Impact factor: 5.223

4.  The validity of hospital discharge register data on coronary heart disease in Finland.

Authors:  M Mähönen; V Salomaa; M Brommels; A Molarius; H Miettinen; K Pyörälä; J Tuomilehto; M Arstila; E Kaarsalo; M Ketonen; K Kuulasmaa; S Lehto; H Mustaniemi; M Niemelä; P Palomäki; J Torppa; T Vuorenmaa
Journal:  Eur J Epidemiol       Date:  1997-06       Impact factor: 8.082

5.  The feasibility of routine mortality and morbidity register data linkage to study the occurrence of acute coronary heart disease events in Finland. The Finnish Cardiovascular Diseases Registers (CVDR) Project.

Authors:  M Mähönen; V Salomaa; I Keskimäki; V Moltchanov
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

6.  The new old epidemic of coronary heart disease.

Authors:  L Bonneux; J J Barendregt; P J van der Maas
Journal:  Am J Public Health       Date:  1999-03       Impact factor: 9.308

7.  Validity of diagnoses of major coronary events in national registers of hospital diagnoses and deaths in Finland.

Authors:  J M Rapola; J Virtamo; P Korhonen; J Haapakoski; A M Hartman; B K Edwards; O P Heinonen
Journal:  Eur J Epidemiol       Date:  1997-02       Impact factor: 8.082

8.  Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies.

Authors:  Peter Klemets; Outi Lyytikäinen; Petri Ruutu; Jukka Ollgren; J Pekka Nuorti
Journal:  BMC Infect Dis       Date:  2008-07-22       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.